ES2097083B1 - Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas. - Google Patents
Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas.Info
- Publication number
- ES2097083B1 ES2097083B1 ES09400996A ES9400996A ES2097083B1 ES 2097083 B1 ES2097083 B1 ES 2097083B1 ES 09400996 A ES09400996 A ES 09400996A ES 9400996 A ES9400996 A ES 9400996A ES 2097083 B1 ES2097083 B1 ES 2097083B1
- Authority
- ES
- Spain
- Prior art keywords
- dry
- particles
- particles treated
- procedure
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002245 particle Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920000249 biocompatible polymer Polymers 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000011806 microball Substances 0.000 abstract 2
- 229920000297 Rayon Polymers 0.000 abstract 1
- 238000013019 agitation Methods 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 230000007704 transition Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310030A GB9310030D0 (en) | 1993-05-15 | 1993-05-15 | Dry processed particles and process for the preparation of the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2097083A1 ES2097083A1 (es) | 1997-03-16 |
| ES2097083B1 true ES2097083B1 (es) | 1997-12-01 |
Family
ID=10735537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09400996A Expired - Fee Related ES2097083B1 (es) | 1993-05-15 | 1994-05-11 | Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas. |
Country Status (34)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE381349T1 (de) * | 1993-01-06 | 2008-01-15 | Ipsen Mfg Ireland Ltd | Bioabbaubare polyester zur herstellung ionischer molekularer konjugate mit bioaktiven polypeptiden |
| DK0678018T3 (da) * | 1993-01-06 | 2003-04-28 | Kinerton Ltd | Ion molekylærkonjugater af bionedbrydelige polyestere og bioaktive polypeptider |
| DE19604744A1 (de) | 1996-02-09 | 1997-08-14 | Henkel Kgaa | Technische Di-/Triglyceridgemische |
| IE960308A1 (en) | 1996-04-23 | 1997-11-05 | Kinerton Ltd | Sustained release ionic conjugate |
| DE19617137C1 (de) * | 1996-04-29 | 1997-02-27 | Henkel Kgaa | Verwendung von Copolymerestern für die Herstellung von Mikrosphären |
| US5858531A (en) * | 1996-10-24 | 1999-01-12 | Bio Syntech | Method for preparation of polymer microparticles free of organic solvent traces |
| US6867181B1 (en) | 1997-06-02 | 2005-03-15 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| EP1183014B1 (en) * | 1999-06-14 | 2003-10-08 | Cosmo S.p.A. | Controlled release and taste masking oral pharmaceutical compositions |
| DK1229940T3 (da) | 1999-11-15 | 2014-08-18 | Piramal Healthcare Canada Ltd | Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning |
| US6646083B2 (en) | 2000-06-16 | 2003-11-11 | Nippon Shokubai Co., Ltd. | Crosslinked polymers containing tertiary amine and/or quaternary ammonium salt structures, processes for making and uses thereof |
| GB0705159D0 (en) * | 2007-03-19 | 2007-04-25 | Prosonix Ltd | Process for making crystals |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH468192A (de) * | 1964-06-19 | 1969-02-15 | Ciba Geigy | Verfahren zur Herstellung von Arzneimitteln in Perlenform |
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| CH672887A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1987-10-14 | 1990-01-15 | Debiopharm Sa | |
| AU2810189A (en) * | 1987-10-30 | 1989-05-23 | Stolle Research & Development Corporation | Low residual solvent microspheres and microencapsulation process |
| DE3916020C2 (de) * | 1989-05-17 | 1994-06-01 | Burkhard Dr Wichert | Retardierende Mikropartikel aus bioabbaubaren Polyestern; Verfahren zu deren Herstellung unter Verzicht auf toxische Lösungsmittel und diese Mikropartikel enthaltende pharmazentische Zubereitungen |
| ATE145131T1 (de) * | 1990-04-12 | 1996-11-15 | Shionogi & Co | Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung |
| JP3116311B2 (ja) * | 1990-06-13 | 2000-12-11 | エーザイ株式会社 | マイクロスフィアの製法 |
| GB2246514B (en) * | 1990-08-01 | 1993-12-15 | Scras | Sustained release pharmaceutical compositions and the preparation of particles for use therein |
| GB9016885D0 (en) * | 1990-08-01 | 1990-09-12 | Scras | Sustained release pharmaceutical compositions |
| SE9003296L (sv) * | 1990-10-16 | 1992-04-17 | Kabi Pharmacia Ab | Foerfarande foer att formulera laekemedel |
| CA2055522A1 (en) * | 1990-12-12 | 1992-06-13 | Masako Andoh | Microspheres for ophthalmic use |
| SE9101603L (sv) * | 1991-05-27 | 1992-09-21 | Bengt Hjalmar Aagerup Med Firm | Metod foer att framstaella reproducerbara partiklar av definierad storlek |
| GB9203689D0 (en) * | 1992-02-20 | 1992-04-08 | Euro Celtique Sa | Pharmaceutical composition |
| JPH07507768A (ja) * | 1992-03-12 | 1995-08-31 | アルカーメス コントロールド セラピューティクス，インコーポレイテッド | Ａｃｔｈ含有マイクロスフェアの制御放出 |
| SE9200858L (sv) * | 1992-03-20 | 1993-09-21 | Kabi Pharmacia Ab | Metod för framställning av pellets med fördröjd frisättning |
| ATE222500T1 (de) * | 1992-06-11 | 2002-09-15 | Alkermes Inc | Enythropoietin enthaltendes arzneimittelabgabesystem |
| US5350584A (en) * | 1992-06-26 | 1994-09-27 | Merck & Co., Inc. | Spheronization process using charged resins |
| JP2651320B2 (ja) * | 1992-07-16 | 1997-09-10 | 田辺製薬株式会社 | 徐放性マイクロスフェア製剤の製造方法 |
| FR2693905B1 (fr) * | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
| GB2273874A (en) * | 1992-12-31 | 1994-07-06 | Pertti Olavi Toermaelae | Preparation of pharmaceuticals in a polymer matrix |
-
1993
- 1993-05-15 GB GB939310030A patent/GB9310030D0/en active Pending
-
1994
- 1994-04-28 GR GR940100215A patent/GR1002034B/el not_active IP Right Cessation
- 1994-05-05 SE SE9401557A patent/SE519004C2/sv not_active IP Right Cessation
- 1994-05-06 HU HU9401412A patent/HU220617B1/hu not_active IP Right Cessation
- 1994-05-09 BE BE9400480A patent/BE1008323A3/fr not_active IP Right Cessation
- 1994-05-09 CH CH01436/94A patent/CH688572A5/fr not_active IP Right Cessation
- 1994-05-11 LU LU88482A patent/LU88482A1/fr unknown
- 1994-05-11 OA OA60510A patent/OA09939A/fr unknown
- 1994-05-11 AT AT0098794A patent/AT406017B/de not_active IP Right Cessation
- 1994-05-11 IT ITMI940931A patent/IT1269508B/it active IP Right Grant
- 1994-05-11 FR FR9405782A patent/FR2705232B1/fr not_active Expired - Fee Related
- 1994-05-11 ES ES09400996A patent/ES2097083B1/es not_active Expired - Fee Related
- 1994-05-12 CA CA002123481A patent/CA2123481C/en not_active Expired - Fee Related
- 1994-05-12 IE IE039294A patent/IE940392A1/en not_active IP Right Cessation
- 1994-05-13 RU RU94016386A patent/RU2125869C1/ru active
- 1994-05-13 SG SG1996006870A patent/SG46631A1/en unknown
- 1994-05-13 IN IN595DE1994 patent/IN182330B/en unknown
- 1994-05-13 PL PL94303441A patent/PL175780B1/pl not_active IP Right Cessation
- 1994-05-13 BR BR9401968A patent/BR9401968A/pt not_active Application Discontinuation
- 1994-05-13 NZ NZ260520A patent/NZ260520A/en not_active IP Right Cessation
- 1994-05-13 DK DK054994A patent/DK171454B1/da not_active IP Right Cessation
- 1994-05-13 FI FI942222A patent/FI112915B/fi active
- 1994-05-13 JP JP06099745A patent/JP3139913B2/ja not_active Expired - Fee Related
- 1994-05-13 MA MA23503A patent/MA23194A1/fr unknown
- 1994-05-13 CN CN94105512A patent/CN1050534C/zh not_active Expired - Fee Related
- 1994-05-13 TN TNTNSN94046A patent/TNSN94046A1/fr unknown
- 1994-05-13 ZA ZA943316A patent/ZA943316B/xx unknown
- 1994-05-13 PT PT101518A patent/PT101518B/pt not_active IP Right Cessation
- 1994-05-13 NO NO941810A patent/NO307403B1/no not_active IP Right Cessation
- 1994-05-13 AU AU63084/94A patent/AU685094B2/en not_active Ceased
- 1994-05-13 GB GB9409565A patent/GB2277915B/en not_active Expired - Fee Related
- 1994-05-13 DE DE4416812A patent/DE4416812C2/de not_active Expired - Fee Related
- 1994-05-14 KR KR1019940010570A patent/KR100341261B1/ko not_active Expired - Fee Related
- 1994-05-15 DZ DZ940045A patent/DZ1779A1/fr active
- 1994-05-16 NL NL9400795A patent/NL9400795A/nl active Search and Examination
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2097083B1 (es) | Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas. | |
| Ci et al. | Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel | |
| RU2700162C2 (ru) | Расширенная под вакуумом сухая композиция и шприц для ее сохранения | |
| RU2715235C2 (ru) | Сухая композиция для использования при гемостазе и заживлении ран | |
| US9795714B2 (en) | FGF-18 formulation in alginate/collagen hydrogels | |
| EP3107590B1 (en) | Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections | |
| EP0109188A1 (en) | Lyophilized compositions, preparation and use thereof | |
| PT643963E (pt) | Dispositivo biodegradavel para administracao de substancias activas | |
| PT637933E (pt) | Metodo para tratamento de orgaos e tecidos | |
| GEP20022707B (en) | Biodegrading Macromers for the Controlled Release of Biologically Active Substances | |
| Mi et al. | Intra-articular versus intravenous tranexamic acid application in total knee arthroplasty: a meta-analysis of randomized controlled trials | |
| ES2331148T3 (es) | Material de implante deformable. | |
| RU96119944A (ru) | Комбинация тромболитически активных белков и антикоагулянтов и их применение | |
| McKim et al. | Dimethyl sulfoxide USP, PhEur in approved pharmaceutical products and medical devices | |
| Perez et al. | Core–shell designed scaffolds of alginate/alpha‐tricalcium phosphate for the loading and delivery of biological proteins | |
| Makihara et al. | Formation of osteon‐like structures in unidirectional porous hydroxyapatite substitute | |
| Sidler et al. | Transcutaneous treatment with vetdrop® sustains the adjacent cartilage in a microfracturing joint defect model in sheep | |
| Grindy et al. | Hydrogel device for analgesic drugs with in-situ loading and polymerization | |
| WO1995016435A3 (en) | Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent | |
| EP1818039A2 (de) | Lokales Wirkstofffreisetzungssystem und ein Verfahren zu seiner Herstellung | |
| KR102451111B1 (ko) | 비타민 d 및 비타민 d 유도체를 포함하는 용해성 미세바늘 패치 | |
| Wang et al. | Heparin-based polyelectrolyte complex enhances the therapeutic efficacy of bone morphogenetic protein-2 for posterolateral fusion in a large animal model | |
| Wilkins et al. | Bread mold osteomyelitis in the femur | |
| Schmidmaier et al. | Selection of graft expanders for the second stage of the induced membrane technique | |
| Gelfand et al. | Combination therapy for enterococcal endocarditis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19970316 Kind code of ref document: A1 Effective date: 19970316 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20180806 |